POWDER; INHALATION
| 0.25MG/INH;EQ 0.05MG BASE/INH
| Prescription
| (Reference Drug)
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
| fluticasone, salmeterol drug combination
| GLAXOSMITHKLINE
| 21077
2011-07-05 Letter 2011-05-16 Label 2011-05-16 Medication Guide 2011-05-12 Letter 2011-02-02 Other 2011-01-07 Letter 2011-01-05 Medication Guide 2010-06-29 Letter 2010-06-28 Label 2009-12-04 Other 2009-11-16 Medication Guide 2009-04-03 Letter 2008-08-01 Review 2008-07-16 Summary Review 2008-05-02 Label 2008-05-01 Letter 2007-09-24 Review 2007-03-01 Letter 2007-02-26 Label 2006-10-02 Letter 2006-09-28 Label 2006-03-23 Letter 2006-03-03 Label 2005-11-30 Other Important Information from FDA 2004-10-04 Label 2004-10-04 Letter 2004-05-04 Label 2004-04-29 Letter 2003-12-02 Label 2003-11-25 Letter 2003-08-28 Review 2003-08-15 Letter 2003-08-15 Label 2002-08-21 Letter |